# Ido Zairi

> Ido Zairi is a venture - series unknown investor at Israel Biotech Fund backing Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Israel Biotech Fund](https://shizune.co/investors/profile/israel-biotechfund)
- Location: New York, United States
- Total investments: 1
- Last investment: Nov 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ido-zairi-b980884
- Website: https://x.com/IdoZairi
- Facebook: https://www.facebook.com/ido.zairi

Ido Zairi is a venture - series unknown investor at Israel Biotech Fund in New York focused on Health Care and Therapeutics. Ido Zairi is based out of Rehovot, HaMerkaz and is the Co-Founder and General Partner of Israel Biotech Fund and Managing Director of Mendham Investment Group. Ido previously worked at Jefferies as a Managing Director, Head of Risk Management. Ido Zairi attended the Hebrew University of Jerusalem.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vensica Medical | Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates. | $16M | Venture - Series Unknown | Nov 01, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Agriline](https://shizune.co/investors/profile/agriline) — VC Fund, 1 deal together
- [Laborie Medical Technologies](https://shizune.co/investors/profile/laborie-medical-technologies) — VC Fund, 1 deal together
- [Trendlines Group](https://shizune.co/investors/profile/trendlines-group) — VC Fund, 1 deal together

## About Israel Biotech Fund

VC Fund · Rehovot, Israel

Israel Biotech Fund – Building the future of Israeli BiotechIsrael Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies.Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages.Ourpartners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance.We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

5 contacts available at Israel Biotech Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Ido Zairi | Co-Founder and Managing Partner | https://shizune.co/investors/profile/ido-zairi |
| Yuval Cabilly | Co-Founder and General Partner | https://shizune.co/investors/profile/yuval-cabilly |
| David Sidransky | Co-Founder and General Partner | https://shizune.co/investors/profile/david-sidransky |
| Jeffrey B. Kindler | Fund Advisor | https://shizune.co/investors/profile/jeffrey-b-kindler |
| Jonathan Fassberg | Fund Advisor | https://shizune.co/investors/profile/jonathan-fassberg |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Ido Zairi invest in?

Ido Zairi invests primarily in Health Care, Therapeutics and Medical Device startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ido Zairi last invest?

The most recent investment recorded for Ido Zairi closed in Nov 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co